Solazyme Inc. (NASDAQ:TVIA) was down 3.1% during mid-day trading on Monday . The company traded as low as $2.53 and last traded at $2.54, with a volume of 106,710 shares changing hands. The stock had previously closed at $2.62.

The stock’s 50 day moving average price is $2.43 and its 200-day moving average price is $2.12. The company’s market capitalization is $211.48 million.

Solazyme (NASDAQ:TVIA) last announced its earnings results on Monday, August 8th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.29) by $0.03. During the same quarter in the prior year, the company earned $0.40 EPS. The company earned $9.90 million during the quarter, compared to the consensus estimate of $10.85 million. The business’s quarterly revenue was down 15.4% on a year-over-year basis. Analysts anticipate that Solazyme Inc. will post ($1.12) EPS for the current year.

In other news, CFO Tyler Painter sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $2.67, for a total transaction of $33,375.00. Following the completion of the transaction, the chief financial officer now owns 400,337 shares in the company, valued at approximately $1,068,899.79. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.